Abstract OBJECTIVE: To explore whether fecal calprotectin (f-calprotectin, FC) may be an early marker for the identification of gastrointestinal injury in preterm infants by measuring FC concentration and changes of FC concentration in infants with different perinatal factors. METHODS: FC concentration was measured using ELISA in 76 samples (50-100 mg) obtained from 38 preterm infants (gestation 29 to 33 weeks), at birth and on the third day after birth (the 1st and the 2nd FC levels). The infants were classified into three groups according to the reason for preterm birth: premature rupture of membranes (PROM; n=13), spontaneous preterm birth (SPB; n=5) and indicated preterm birth (IPB; n=20). RESULTS: There were no significant differences between the 1st and 2nd FC levels in the 38 infants. The 1st FC level in the PROM group was significantly higher than that in the IPB group (P<0.05). The 1st FC level in infants whose mothers received antenatal antibiotics treatment was significantly lower. Infants born by cesarean section had a significantly lower 1st FC level than those born by vaginal delivery (P<0.05). Both the 1st and 2nd FC levels in infants with feeding intolerance were significantly higher than in infants with feeding tolerance (P<0.05). The 2nd FC level was negatively correlated with 1 min Apgar score (r=-0.3, P<0.05). CONCLUSIONS: Premature rupture of membranes and perinatal asphyxia may lead to an increase in the excretion of FC in preterm infants. FC may be used as a marker for early evaluation of gastrointestinal conditions in preterm infants.
［1］Neu J, Zhang L. Feeding intolerance in very-low-birthweight infants: what is it and what can we do about it?［J］. Acta Paediatr Suppl, 2005, 94(449): 93-99.
［2］Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease［J］. J Pediatr Gastroenterol Nutr, 2001, 32(2): 171-177.
［3］Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children［J］. Acta Paediatr, 2002, 91(1): 45-50.
［4］Campeotto F, Kalach N, Lapillonne A, Butel MJ, Dupont C, Kapel N, et al. Time course of faecal calprotectin in preterm newborns during the first month of life［J］. Acta Paediatr, 2007, 96(10):1531-1533.
［5］Carroll D, Corfield A, Spicer R, Cairns P. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis［J］. Lancet, 2003, 361(9354):310-311.
［6］Goldenberg RL, Culhane JF, Iams JD, Romero R.Epidemiology and cause of preterm birth［J］.Lancet, 2008, 371(9606): 75-84.
［7］Ng E, Shah V. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants［J］.Cochrane Database Syst Rev, 2008, (3): CD001815.
［8］Campeotto F, Baldassarre M, Butel M, Viallon V, Nganzali F, Soulaines P, et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants［J］. J Pediatr Gastroenterol Nutr, 2009, 48(4): 507-510.
［9］Josefsson S, Bunn SK, Domell-f M. Fecal calprotectin in very low birth weight infants［J］. J Pediatr Gastroenterol Nutr, 2007, 44(4): 407-413.
［10］Yang Q, Smith PB, Goldberg RN, Cotten CM. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life［J］.Neonatology, 2008, 94(4): 267-271.
［11］Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery［J］. J Pediatr Gastroenterol Nutr, 1999, 28(1): 19-25.
［13］Rougé C, Butel MJ, Piloquet H, Ferraris L, Legrand A, Vodovar M, et al. Fecal calprotectin excretion in preterm infants during the neonatal period［J］. PLoS One, 2010, 5(6): e11083.
